Inventor · disambiguated record
Michael Ming-Jin Poe
Also filed as: POE MICHAEL MING-JIN
6 granted patents·3 pending applications·18 citations·filing 2012–2024
79Inventor score
Top patents by PatentIndex Score
9 records- 0186US9006233B2Gabaergic receptor subtype selective ligands and their usesCOOK JAMES M·Filed 2012·Granted Apr 14, 2015·8 cites·3 claims
- 0282US11753412B2Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatric disorders with Alpha5-containing GABAA receptor agonistsUWM RES FOUNDATION INC·Filed 2020·Granted Sep 12, 2023·1 cites·46 claims
- 0382US9597342B2GABAergic receptor subtype selective ligands and their usesUWM RES FOUND INC·Filed 2015·Granted Mar 21, 2017·4 cites·1 claims
- 0479US12180216B2Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatric disorders with alpha5-containing GABAA receptor agonistsUWM RES FOUNDATION INC·Filed 2023·Granted Dec 31, 2024·0 cites·12 claims
- 0578US10259815B2Gabaergic ligands and their usesUWM RES FOUNDATION INC·Filed 2016·Granted Apr 16, 2019·4 cites·22 claims
- 0678US2025179080A1Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatric disorders with alpha5-containing gabaa receptor agonistsUWM RES FOUNDATION INC·Filed 2024·Application pending·0 cites
- 0772US10906909B2Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatric disorders with ALPHA5-containing GABAA receptor agonistsUWM RES FOUNDATION INC·Filed 2017·Granted Feb 2, 2021·1 cites·7 claims
- 0853US2024279232A1Use of substituted 5-(4-methyl-6-phenyl-4h-benzo[f]imidazo[1,5-a][1,4] diazepin-3-yl)-1,2,4-oxadiazoles in the treatment of inflammatory conditionsUWM RES FOUNDATION INC·Filed 2021·Application pending·0 cites
- 0947US2019300534A1Gabaergic ligands and their usesUWM RES FOUNDATION INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Ming-Jin Poe files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →